OPKO Health (NASDAQ: OPK) reported Q2 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $314.2 million versus the consensus estimate of $322.64 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.